Olga Morozova
Olga Morozova
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine
O Morozova, S Dvoryak, FL Altice
International Journal of Drug Policy 24 (6), e91-e98, 2013
412013
Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia
O Morozova, O Levina, A Uusküla, R Heimer
BMC medical research methodology 15 (1), 71, 2015
372015
Ukrainian prisoners and community reentry challenges: implications for transitional care
O Morozova, L Azbel, Y Grishaev, S Dvoryak, JA Wickersham, FL Altice
International journal of prisoner health 9 (1), 5-19, 2013
162013
Primary healthcare-based integrated care with opioid agonist treatment: first experience from Ukraine
O Morozova, S Dvoriak, I Pykalo, FL Altice
Drug and alcohol dependence 173, 132-138, 2017
142017
Risk ratios for contagious outcomes
O Morozova, T Cohen, FW Crawford
Journal of The Royal Society Interface 15 (138), 20170696, 2018
122018
Retention in medication-assisted treatment programs in Ukraine—Identifying factors contributing to a continuing HIV epidemic
K Dumchev, S Dvoryak, O Chernova, O Morozova, FL Altice
International Journal of Drug Policy 48, 44-53, 2017
122017
HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy
K LaMonaca, K Dumchev, S Dvoriak, L Azbel, O Morozova, FL Altice
Current psychiatry reports 21 (7), 47, 2019
72019
Interpretation of the individual effect under treatment spillover
FW Crawford, O Morozova, AL Buchanan, D Spiegelman
American journal of epidemiology 188 (8), 1407-1409, 2019
52019
Randomization for the direct effect of an infectious disease intervention in a clustered study population
DJ Eck, O Morozova, FW Crawford
arXiv preprint arXiv:1808.05593, 2018
52018
Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis
O Morozova, FW Crawford, T Cohen, AD Paltiel, FL Altice
Addiction 115 (3), 437-450, 2020
32020
A model for COVID-19 transmission in Connecticut
O Morozova, ZR Li, FW Crawford
medRxiv, 2020
32020
Correlates of recent HIV testing among transgender women in Greater Kuala Lumpur, Malaysia
R Rutledge, O Morozova, BA Gibson, FL Altice, A Kamarulzaman, ...
LGBT health 5 (8), 484-493, 2018
32018
Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine
J Rozanova, O Morozova, L Azbel, C Bachireddy, JM Izenberg, ...
Journal of urban health 95 (4), 508-522, 2018
32018
COVID-19 projections for reopening Connecticut
FW Crawford, ZR Li, O Morozova
medRxiv, 2020
12020
HIV Epidemic Among Key Populations in Ukraine: Review of Secondary Data
A Boyko, M DiCarlo, O Doroshenko, O Morozova, L Sherburne
Edited by. Kyiv, Ukraine, 2013
12013
Divergent estimates of HIV incidence among people who inject drugs in Ukraine
O Morozova, RE Booth, S Dvoriak, K Dumchev, Y Sazonova, T Saliuk, ...
International Journal of Drug Policy 73, 156-162, 2019
2019
Randomization for the susceptibility effect of an infectious disease intervention
DJ Eck, O Morozova, FW Crawford
arXiv, arXiv: 1808.05593, 2018
2018
Methodological Topics in Infectious Diseases and Substance Abuse Epidemiology
O Morozova
Yale University, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18